ULTRALIFE CORPORATION (ULBI) Return on equity 2016–2025
ULTRALIFE CORPORATION (ULBI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-4.5%FY2025 · since FY2016: 5.2% → -4.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.5% | -9.2 pp |
| FY2024 | 4.7% | -1.0 pp |
| FY2023 | 5.7% | +5.8 pp |
| FY2022 | -0.1% | +0.1 pp |
| FY2021 | -0.2% | -4.7 pp |
| FY2020 | 4.5% | -0.3 pp |
| FY2019 | 4.7% | -19.1 pp |
| FY2018 | 23.8% | +14.2 pp |
| FY2017 | 9.7% | +4.5 pp |
| FY2016 | 5.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice